Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1997; 197: 263–5.
Aisen P, Listowsky I. Iron transport and storage proteins. Ann Rev Biochem 1980; 49: 357–93.
Shau H, Kim A, Golub H. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukocyte Biol 1992; 51: 343–9.
Horwitz DA, Bakke AC, Abo W, Nishiya K. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J Immunol 1984; 132: 2370–4.
Gahr M, Speer CP, Damerau B, Sawatzki G. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J Leukocyte Biol 1991; 49: 427–33.
Sawatzki G, Rich IN. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 1989; 371–85.
Gentile P, Boxmeyer HE. Suppression of mouse myeclopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin. Blood 1983; 61: 982–93.
Sekine K, Watanabe E, Nakamura J et al. Inhibition of azoxymethaneinitiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res 1997; 88: 523–6.
Sekine K, Ushida Y, Kuhara T et al. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administrated bovine lactoferrin concomitantly with azoxymethane. Cancer Lett 1997; 121: 211–6.
Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumor and development of experimental metastases in mice. Cancer Res 1994; 54: 2310–2.
Yoo Y-C, Watanabe S, Watanabe R et al. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 1997; 88: 184–90.
Iigo M, Tsuda H, Moriyama M. Enhanced therapeutic effects of antitumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2. Clin Exp Metastasis 1994; 12: 368–74.
Iigo M, Nishikata K, Nakajima Y, Araki E. Effects of antitumour agents on subcutaneous implants and hepatic metastases of colon carcinoma 26 in mice. Jpn J Cancer Res 1992; 83: 397–401.
Iigo M, Shimamura M, Sagawa K, Tsuda H. Characteristics of the inhibitory effect of mitoxantrone and pirarubicin on lung metastases of colon carcinoma 26. Jpn J Cancer Res 1995; 86: 867–72.
Tomita M, Bellamy W, Takase M et al. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 1992; 4137–42.
Moriyama M, Harada K, Kawasaki H et al. Characterization of extrathymic T cells induced by recombinant murine interferon-β in the peritoneal cavity of nude mice. J Interferon Cytokine Res 1995; 15: 925–31.
Glazer RI, Lloyd LS. Association of cell lethality with incorporation of 5–fluorouracil and 5–fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Mol Pharmacol 1982; 21: 468–73.
Riviere Y, Hovanessian AG. Antitumoral action of interferon and poly(A)poly(U) on Hela xenografts in the nude mouse. Ann Immunol 1984; 135: 333–43.
Piscatelli JJ, Cohen SA, Berenson CS, Lance P. Determinants of differential liver-colonizing potential of variants of the MCA-38 murine colon cancer cell line. Clin Exp Metastasis 1995; 13: 141–50.
Cavacini LA, Giles-Komar J, Kennel M, Quinn A. Effect of immunosuppressive therapy on cytolytic activity of immuno deficient mice: implications for xenogeneic transplantation. Cell Immunol 1992; 144: 296–310.
Migliore-Samour D, Floch'h F, Jolle's P. Biologically active casein peptides implicated in immuno-modulation. J Dairy Res 1989; 56: 357–62.
Shinoda I, Takase M, Fukuwatari Y et al. Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes. Biosci Biotech Biochem 1996; 60: 521–3.
Arenberg DA, Kunkel SL, Polverini PJ et al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996; 97: 2792–802.
Singh RK, Gutman M, Radinsky R et al. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 3242–7.
Ueda T, Shimada E, Urakawa T. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 1994; 29: 423–9.